search
Nature Medicine
Trends
- 1
A new Nature article examines the convergence of synthetic biology with bioprocess engineering, a combination seen as key to scaling laboratory-designed biological systems into industrial production. Merging the two fields could accelerate manufacturing of medicines, chemicals and materials using engineered organisms, though details of the article's findings and the wider response to it remain limited.
- 2ALX Oncology publishes promising evorpacept gastric cancer trial data in Nature Medicine▼ALX Oncology Announces Nature Medicine Publication of ASPEN-06 Phase 2 Clinical Data Demonstrating Strong Responses and Durable Clinical Benefit with Evorpacept in HER2-Positive Gastric Cancer
ALX Oncology announced that Nature Medicine has published Phase 2 results from its ASPEN-06 trial, showing strong responses and durable clinical benefit with evorpacept combined with trastuzumab and chemotherapy in patients with HER2-positive gastric cancer. The publication adds peer-reviewed weight to the company's lead drug candidate and supports its ongoing development program in gastroesophageal cancers.